Considerable evidence suggests that sexual transmission of human immunodeficiency virus (HIV) is mediated via mononuclear cells that can infect epithelia of the genital tract. We describe here an in vitro model that can be used to examine the mechanism of cell-to-cell transmission of this virus. We have employed the system to identify agents that may be effective in a vaginal formulation to prevent HIV transmission via sexual contact.
INTRODUCTION
Throughout most of the world, the number of individuals infected with the human immunodeficiency virus (HIV) continues to increase at an alarming rate. Fortunately, the efforts of scientists in many disciplines of biology have facilitated an unprecedented understanding of the mechanisms of HIV pathogenesis. This information has led to the development of strategies to prevent and treat HIV infection that one hopes will lead to a successful vaccine in the future. There has been relatively little interest in the mechanism(s) of sexual transmission of HIV. In this area, the reproductive biologist's understanding of the structure and function of the reproductive organs, and experience with techniques for the study of the reproductive tract, may contribute uniquely toward understanding of the mechanism(s) of sexual transmission of HIV. We hope that the present report will stimulate interest among reproductive biologists in the AIDS pandemic.
HIV was originally thought to infect only cells that express CD4, the principal HIV cell-surface receptor molecule. Since epithelial cells lining the vagina, urethra, and gastrointestinal tract do not express CD4, workers in the field postulated that sexual transmission of HIV must require lesions in the epithelium. However, several lines of evidence now support an alternative hypothesis, namely, that virus-carrying white blood cells can directly infect epithelial cells, which in turn transmit virus across the intact epithelium. Once the virus reached the other side of the genital tract or gut epithelium, it would be free to infect lymphocytes or macrophages in the underlying connective tissue.
Evidence of HIV infection of epithelial cells comes from both in vitro and in vivo studies. A number of cell types that do not express surface CD4 have been productively infected with HIV. These permissive cell types include various CD4-negative epithelial cell lines [1] [2] [3] [4] [5] [6] [7] [8] [9] . Nelson and colleagues [10] have shown that chromaffin cells in the crypts of the bowel of some homosexual seropositive individuals carry HIV. Recently, HIV was recovered from biopsy tissues of the small bowel, colon, and rectum of seropositive individuals with severe diarrhea [11] ; and Heise et al. [12] demonstrated HIV infection of enterocytes in human jejunal mucosa from a homosexual seropositive individual. Furthermore, there is evidence that HIV can cross M cells in the intestine [13] ; and it has been suggested that CD4-positive Langerhans cells, present in the vaginal epithelium, may serve as a route of HIV infection [14] [15] [16] [17] .
Epithelial cells and their derivative cell lines are inherently polar in both structure and function. It appears that polarity is maintained during the infectious process; virus appears to be secreted primarily from the basolateral sur-faces [8, 18, 19] . If these in vitro results apply to the natural sequence of events, the implication is that secretion of new virus would be through the basolateral membrane and towards the underlying connective tissue target lymphocytes and macrophages.
Although most pathogens have mechanisms that promote their transport and the infection of target cells without employing host cells, considerable evidence suggests that many viruses utilize cell-cell mechanisms to infect. Cellto-cell spread has been described in paramyxoviruses [20] [21] [22] , vaccinia [23] , foamy virus [24] , herpesvirus [25] [26] [27] , and retroviruses such as bovine leukemia virus and [28] visna virus [29, 30] . The observation that infection is easier with human T cell leukemia virus type I (HTLV-I)-infected lymphocytes than with free virus suggests that a cell-cell mechanism may also predominate in this retrovirus [31] [32] [33] [34] [35] . In addition, a number of reports have suggested that cell-tocell spread may be the main route of infection by HIV [36] [37] [38] [39] [40] [41] [42] [43] [44] . Retroviruses may thus take advantage of a unique opportunity: the cell types that they infect, lymphocytes and monocytes/macrophages, are found in both semen [45] and in blood, which is normally present in the vagina during menses. Evidence that it is easier to infect lymphocytes with HIV-infected mononuclear cells than with free virus isolated from semen of HIV-infected men further supports this hypothesis [37, 39, 46, 47] .
Our laboratory has developed an in vitro system to demonstrate that HIV-infected monocytes or lymphocytes can infect epithelia. When low-secreting, chronically HIV-infected lymphocyte-or monocyte-derived cells are added to epithelial monolayers, we observe that they rapidly attach to the epithelium. Adherence promptly triggers profuse, directional budding of viruses onto the surface of the epithelium. Virions appear to be sequestered in a partially enclosed space between the two cell types. Ultrastructural examination suggests that virions may enter the epithelium by direct fusion with the plasma membrane, coated pits, or large smooth vesicles. Productive infection of the epithelium has been shown by in situ hybridization, lymphocyte coculture, ELISA, and reverse transcriptase assay [4, 5] . We have also observed that HTLV-I is transmitted via a similar lymphocyte-to-epithelial mechanism [48] .
We believe that our in vitro model may mimic a natural route of sexual transmission of HIV. The cell-to-cell model of transmission is attractive because it results in the secretion of numerous virions onto the epithelial surface immediately after cell-cell adhesion. Shedding and uptake of virus occurs so quickly that virions may be able to escape immune surveillance.
An initial and crucial step in epithelial infection, via this cell-to-cell model, is adherence of the lymphocyte or monocyte/macrophage to the epithelium. Thus, an understanding of the factors involved in adherence of lymphocytes or monocytes/macrophages to genital tract and gut epithelia, as well as knowledge of how to inhibit attachment, may lead to strategies for reducing the risk of HIV infection through sexual intercourse. We describe here structural and dynamic aspects of this adherence.
For the studies reported here, we used water-soluble biotin or a fluorescent dye to measure lymphocyte attachment to epithelial cell lines derived from the cervix and intestine. Since sexual transmission of HIV occurs in the presence of semen, we have employed the assay to examine the effect of semen on lymphocyte-to-epithelial cell adherence. This approach was also used to study agents that might be used to block adherence, with the idea that these compounds might be further developed for use in a vaginal formulation to prevent HIV infection.
MATERIALS AND METHODS

Reagents
A number of compounds were tested for their ability to inhibit adhesion of lymphocytes to epithelia. These agents included spermicides and compounds with properties suggesting that they might have an effect on viral transmission or cell adhesion, as follows. Tergitol (NP-9, Sigma Chemical Co., St. Louis, MO), commonly referred to as nonoxynol-9 (N-9), is a nonionic surfactant employed as the active ingredient in most vaginal spermicides. Benzalkonium chloride (B-1383, Sigma) is a cationic surface-active agent also used in vaginal spermicides. Proflavine (3,6-acridinamine, P-4646, Sigma), which is used as a topical antiseptic, has been shown to terminate DNA synthesis [49] . Chloroquine (generously provided by Dr. Yun-Yen Tsong, The Population Council, New York, NY) is a quinone analogue with antimalarial, antiamebic, and antirheumatic properties that is known for its suppressive effect on the immune system in lupus erythematosus. Polyvinylpyrrolidone (PVP-1, Sigma) is used as an antiseptic. Diethyldithiocarbamate (C 5 H, 0 NNaS 2 ) (D-3506, Sigma) is a chelating agent with immunomodulating and T-cell-specific immunostimulant effects [50] . It is also used as an antidote to nickel and cadmium poisoning. The tilorone analogue we used (T-8014, Sigma) also has immunomodulatory effects [51] , possibly via induction of interferon production [52, 53] . Glutathione (G-4251, Sigma) is a reducing agent rich in thiol groups. Chlorophyllin (No. 25,828-8, Aldrich Chemical Co., Milwaukee, WI), which is an analogue of chlorophyll, is a chelating agent. Chondroitin sulfate A (C-8529, Sigma) is a highly viscous mucopolysaccharide that occurs in both skeletal and soft tissue and has antihyperlipoproteinemic activity. Dextran sulfate, molecular weight 500 000 (D-6001, Sigma) is a heparin-like sulfated polysaccharide used as an anticoagulant and is also antihyperlipoproteinemic. It has been shown to possess anti-HIV activity in vitro [54] [55] [56] .
BCECF-AM (No. 1170, Molecular Probes, Eugene, OR), the fluorogenic ester used for cell adhesion assays and cytotoxicity assays, was stored in the dark as 50-pRg aliquots at -20 0 C. chamber and Sage-Boulex 16-mm time-lapse recording system. Cells were photographed on Kodak Plus X reversal film (Eastman Kodak, Rochester, NY) with a 20x phase-contrast objective lens at a frame rate of 1 frame/10 sec. Films were viewed with a Kodak photo optical data analyzer.
Electron Microscopy ME-180 cells or 1-407 cells were seeded at the same density as in the adhesion assay but were grown on 0.45-[lmmembrane Millicell-HA insert chambers (Millipore). Cells were grown for the same length of time and lymphocytes were added at the same cell density as described above for the adhesion assay. After 90 min in a 37 0 C humidified CO 2 incubator, cultures were immediately fixed in 2.5% glutaraldehyde buffered with 0.2 M phosphate buffer at pH 7.2. Fixation was carried out by carefully replacing the medium with fixative. The insert chambers were left in a refrigerator overnight; the next morning filters were cut from the insert chambers, washed in phosphate buffer, and prepared for transmission electron microscopy (TEM) as previously described [4] . Sections were cut on a Reichert OmU3 ultratome and examined with a Philips 300 microscope.
For scanning electron microscopy (SEM), we used cultures grown in microtiter plates as described for the adhesion assay. Cultures were fixed after a 90-min incubation and washed in phosphate buffer. The next day the bottoms of selected wells from the 96-well flat-bottomed microtiter plate were carefully cut from the plate using a 1-inch diameter circular saw blade and a variable speed Moto-tool Jensen Tools, Phoenix, AZ). Care was taken to keep the wells from drying out while they were being cut off. The bottoms of the wells were then dehydrated to 100% ethanol and critical point-dried from alcohol. After mounting on studs, the bottoms of wells were sputter-coated with gold and examined in an ETEC autoscan SEM.
RESULTS
Electron Microscopy
As models for the type of epithelial barriers that HIV must cross during sexual transmission, epithelial cell lines derived from the human cervix (ME-180) and human intestine (1-407) were selected. Both lines are permissive for HIV infection. The 1-407 intestinal cell line has been productively infected with HIV by co-incubation with chronically HIV-infected lymphocytic or monocytic cells [4, 5] ; we have recently found that ME-180 cells can also be infected when co-cultured with chronically HIV-infected lymphocytic cells (unpublished data). Therefore, for the current experiments, the adherence process was studied in these two epithelial cell types.
To examine morphological aspects of the interactions between lymphocytic cells and epithelia, we added lymphocytes to epithelia cultured in microtiter plates and coincubated them for 90 min, after which they were washed and fixed for SEM. In subconfluent cultures, where the surfaces of both the plastic and the epithelial cells could be visualized simultaneously, it was apparent that lymphocytes attached to the epithelium and not to the plastic (Fig. 1) . In addition, a morphological difference was seen between uninfected and HIV-infected lymphocytes after a 90-min coincubation with the epithelium. Adherent uninfected lymphocytic cells retained the generally spherical shape they had in suspension (Fig. 1) , whereas adherent HIV-infected lymphocytes usually became pear-shaped after a 90-min incubation with the epithelium (Fig. 2) . We examined several uninfected lymphocyte and monocyte cell lines after a 90-min incubation with the epithelium, and did not see morphogenesis to pear-shaped cells in any of the co-cultures.
TEM of sections cut perpendicular to the epithelium revealed some variation in the associations between uninfected lymphocytic cells and epithelia. In some instances, the lymphocyte and epithelial cell were in close association, although no junctional complexes were seen between opposing cells. However, in most cases, the cell adherence was via epithelial cell microvilli occurring in association with the lymphocyte plasmalemma; the body of the lymphocyte and partner epithelial cell appeared to be some distance apart (Fig. 3) .
The striking difference between infected and uninfected lymphocytes, as seen by TEM, was the presence of numerous virions in the spaces between the adherent, chronically HIV-infected lymphocyte and the associated epithelial cell (Fig. 4) . Some lymphocytic cells involved in this process assumed a pear shape, while other lymphocytic cells retained their rounded appearance. In some cases, adherence between the lymphocyte and the epithelial cell appeared to induce the formation of epithelial or lymphocyte microvilli, because many microvilli were observed in the contact region. Virtually every polar cell exhibited numerous virions in the microvilli-filled spaces between the adherent lymphocyte and epithelial cell (Fig. 4) .
Time-Lapse Cinematography
We employed time-lapse cinematography to follow the movement of lymphocytes during the 90-min incubation period. The uninfected lymphocytic cells, as photographed with a 20x objective, appeared spherical. When individual cells were followed in a frame-by-frame analysis (10-sec intervals), lymphocytes were seen to move slightly between each frame, although their location did not change over the 90-min period. In other words, the cells rocked from side to side, but they appeared anchored in place to the epithelial cell (Fig. 5) .
Chronically HIV-infected lymphocytic cells had considerably more irregular and less spherical contours than uninfected cells. As was the case with the uninfected cell lines, individual cells shifted position slightly between frames. When individual cells were followed for longer periods of time, they were frequently observed to move considerable distances. Within any 15-min period, some lymphocytes migrated as much as 25 Am from their starting points, while other cells traveled only a few micrometers along the surface of the epithelium. Almost all lymphocytes shifted location during the 90-min incubation period. We did not observe cells detaching from the epithelium (Fig. 6) .
Adhesion Assays
BCECF-AM, the dye used in our fluorescence assay, readily passes through the cell membrane of viable cells and is nonfluorescent until hydrolyzed by intracellular esterases 200 100 50 25 BCECF-AM has not been employed in a cell-cell adhesion system before, we tested its accuracy and sensitivity by add-
phocytes to epithelial cells (see Materials and Methods).
Experiments were repeated three times. Serial dilutions of BCECF-AM-labeled lymphocyte suspensions at an initial concentration from 2 x 105 to 3.9 x 102 cells/well were detectable after co-incubation with epithelial cells (Fig. 7 , a and b). The fluorescence from adherent lymphocytes was found to be directly proportional to the number of lymphocytes added at the beginning of the assay (Fig. 7c) . From the linear regression plot, the correlation coefficient (r) 0.986. To define the lower limit of detection of this assay in terms of absolute number of cells rather than relative fluorescence, an acuional experiment was performed. wofold serial dilutions of fluorochrome-labeled lymphocytes were added to epithelial monolayers, and fluorescence was measured without washing the wells. From these data, the sensitivity was found to be 50 to 100 lymphocytes per well
3.1 1.56 0.78 0. 39 Using the sensitivity data, we estimated the number of . cell adhesion assay (Table 1 ). The calculation was based on the fluorescence from cells remaining attached to the epithelium relative to the fluorescence from a known absolute number of cells added to the epithelium. Regardless of the number of lymphocytes co-incubated with the epithelium, 15% to 19% of lymphocytes remained attached to the epithelium at the end of the assay, suggesting a specific interaction between the two cell types.
Cytotoxicity Assay
Since adhesion can be inhibited by general cytotoxic effects as well as by specific effects on healthy cells, we determined the cytotoxic concentrations under the conditions of the adhesion assay. Five compounds studied by twofold serial dilutions (2 to 0.06 mg/ml) on ME-180 epithelia varied widely in their cytotoxicity (Fig. 9) . N-9 and benzalkonium chloride were 100% cytotoxic over this concentration range. Chlorophyllin showed a dose-dependent effect, being 90% to 100% toxic at high concentrations and 20% toxic at 0.06 mg/ml. Chloroquine was nontoxic over this concentration range, and dextran sulfate showed a dose-dependent effect: 48% toxic at 50 mg/ml and nontoxic at 6.25 mg/ml. The remaining six compounds-glutathione, chondroitin sulfate, diethyldithiocarbamate, proflavine, tilorone, and polyvinylpyrrolidone-were noncytotoxic over this concentration range (Fig. 9) .
Cytotoxicity profiles of the same compounds on CEM-SS lymphocytes showed similar results. N-9 was 100% cytotoxic over this concentration range and nontoxic at 12.5 i,.g/ml. Benzalkonium chloride was less toxic to lymphocytes than to ME-180 cells (44%) at high concentrations, but at low concentrations it was equally cytotoxic (100%) to both cell types. Although chloroquine was nontoxic to ME-180 cells, it was 37% toxic to lymphocytes at 0.5 mg/ml; and cytotoxicity of chlorophyllin was dose-dependent for lymphocytes just as it was for ME-180 cells. Two compounds, tilorone and polyvinylpyrrolidone, were toxic for CEM-SS lymphocytes (79% and 97%, respectively, at 0.5 mg/ ml) but were not toxic for ME-180 cells. Glutathione, chondroitin sulfate, diethyldithiocarbamate, and proflavine were nontoxic, while dextran sulfate was nontoxic at 25 mg/ml or lower (Fig. 10) .
Effect of Compounds on Attachment
N-9, benzalkonium chloride, and chlorophyllin had no inhibitory effect below their cytotoxic doses (Fig. 11) . On the other hand, glutathione, dextran sulfate, and chondroitin sulfate effectively inhibited cell-cell adhesion in a dosedependent manner at concentrations well below cytotoxic levels. Dextran sulfate inhibited 86% of adhesion at 5 mg/ ml; glutathione inhibited 57% at 1 mg/ml; and chondroitin sulfate inhibited 30% at 0.5 mg/ml (Fig. 12) . Dextran sulfate and glutathione also had a dose-dependent effect on HIV-infected lymphocyte adhesion to epithelia: 25 mg/ml dextran sulfate inhibited cell-cell adhesion 44%, and 5 mg/ ml glutathione (noncytotoxic) inhibited cell-cell adhesion 62% (Fig. 13) . Chloroquine and polyvinylpyrrolidone inhibited cell-cell adhesion 44% at 0.5 mg/ml and 44% at 1 mg/ml, respectively (Fig. 12) . However, at these concentrations both compounds are cytotoxic to CEM-SS lymphocytes (37% and 97%, respectively). Some compounds were found to enhance cell-cell adhesion. Proflavine and diethyldithiocarbamate increased the number of lymphocytes remaining attached to the epithelium by 126% and 32%, respectively, at 0.5 mg/ml. Thus, only the sulfated polysaccharides (dextran sulfate and chondroitin sulfate) and glutathione had specific effects on lymphocyte-to-epithelial cell adhesion; therefore these are compounds that may be good candidates for a aNumber of MOLT-4 lymphocytes per well added to 1-407 epithelium at the beginning of the assay. bFluorescence from lymphocytes remaining attached to the epithelium after a 90-min co-incubation with epithelial cells. Data points represent the mean of three wells + S.D.
CNumber of lymphocytes remaining attached to the epithelium after washing; calculated from the corresponding fluorescence value in column 2. dCells remaining attached to the epithelium relative to the number of lymphocytes added initially. *For example, from 390 lymphocytes/well added at the beginning of the adhesion assay, the fluorescence from lymphocytes remaining attached to the epithelium after washing = 25 fluorescence units (F). FIG. 9. Cytotoxicity trials on ME-180 cervix-derived epithelia. Data points represent the mean of three wells (-SD). Ninety-six-well tissue culture plates were seeded at 2 x 104 cells/well 24 h prior to treatment. Eleven compounds were serially diluted twofold in RPMI/1640 + 10% FCS and co-incubated with ME-180 cells for 2 h at 37°C. Plates were then washed in PBS, co-incubated with BCECF-AM (4 Fpg/ml) 30 min at 37°C, and read in a Cytofluor 2300 at excitation 485 nm, emission 530 nm, sensitivity 4. Five compounds are shown to illustrate compounds that were 100% cytotoxic, dosedependent, or noncytotoxic to ME-180 epithelia over the concentration range (2.0-0.06 mg/ml), excluding dextran sulfate (twofold serial dilution from 50 mg/ml to 1.5 mg/ml). The remaining six compounds (glutathione, chondroitin sulfate A, diethyldithiocarbamate, proflavine, tilorone, and polyvinylpyrrolidone) were noncytotoxic. 10 . Cytotoxicity trials on CEM-SS lymphocytes. Data points represent the mean of three wells (+-SD). Conditions were as described in the legend to Figure 9 for cervix-derived epithelia. Five compounds are shown over the concentration range (2.0-0.06 mg/ml). Of the remaining six compounds, glutathione, chondroitin sulfate, diethyldithiocarbamate, and proflavine were noncytotoxic; dextran sulfate was noncytotoxic at concentrations 25 mg/ml; and N-9 was 100% cytotoxic over this concentration range. (Error bars are not presented on some points because they are too small to be seen.) Ninety-six-well plates seeded at a concentration of 2 x 104 epithelia/well were co-incubated with 2 x 105 BCECF-AM-labeled CEM-SS lymphocytes for 90 min at 37°C in the presence or absence of a serial twofold dilution of test compounds as described in Materials and Methods. N-9, benzalkonium chloride, and chlorophyllin had no inhibitory effect below cytotoxic doses.
vaginal formulation to prevent cell-mediated HIV infection. The other compounds appeared to be generally cytotoxic.
Seminal Fluid
Seminal fluid consistently and markedly increased cellcell adhesion at high concentrations. For example, 50% seminal fluid increased the number of lymphocytes adhering to ME-180 cervix-derived epithelia by several fold (Fig.  14) . Similarly, 50% seminal fluid resulted in a twofold increase in the number of lymphocytes adhering to 1-407 intestine-derived epithelia (Fig. 15) .
Because semen is an extremely complex fluid that may vary in its constitution, we repeated each experiment several times using semen from different donors. Although the results were slightly different from donor to donor, we consistently observed significant enhancement of attachment. The effect was consistently more pronounced with ME-180 cells than with 1-407 cells. Although the protein concentration is 5% in neat seminal fluid, this observation appears to be due to a specific effect of seminal fluid rather than to a nonspecific effect of protein on cell-cell adhesion; human serum had no effect on cell-cell adhesion titrated to the same protein concentration as seminal fluid (data not shown). (Protein concentration is 7% to 9% in neat serum.) HIV-infected lymphocytes showed a similar effect. Seminal fluid at a concentration of 50% increased the number of HIV-infected H9 cells adhering to ME-180 epithelial cells by FIG. 12 . Effect of compounds on cell-cell adhesion. Data points represent the mean of three wells ( SD). (Error bars are not presented on some points because they are too small to be seen.) Conditions were the same as described in the legend to Figure 11 , except that different compounds were tested. Glutathione and dextran sulfate (twofold serial dilution from 50 mg/ml to 1.5 mg/ml) effectively inhibited cell-cell adhesion in a dose-dependent manner at concentrations below cytotoxic levels. Chloroquine and polyvinylpyrrolidone had no effect on cell-cell adhesion below cytotoxic levels.
about the same amount as it did adherent uninfected H9 cells (Fig. 16) .
DISCUSSION
Sexual transmission of HIV could conceivably occur via cell-cell mechanisms, via infection of epithelia by free virus, or via lesions in the epithelium. It is also not clear whether FIG. 13 . Effect of compounds on adhesion of HIV-infected lymphocytes to epithelia. C: control, untreated cultures. Glutathione (5 mg/ml to 0.15 mg/ml) and dextran sulfate (50 mg/ml to 1.5 mg/ml) effectively inhibited cell-cell adhesion in a dose-dependent manner at concentrations below cytotoxic levels. infection occurs through the vaginal epithelium and/or cervix in women or through the skin of the penis or urethra in men. Although there has been considerable indirect evidence for HIV infection via free virus, cell-cell transmission, or lesions, much more work needs to be done before we can be clear about the routes of HIV infection. In the present paper, we have addressed only the problem of transmission, via a lymphocyte-mediated mechanism, to epithelia derived from the gut or cervix. However, there is good reason to believe that cell-cell transmission may be a major mechanism of HIV infection from semen. There has been only one report [63] documenting cell-free HIV in substantial titer (108 particles/ml) in seminal fluid. Generally, cellfree HIV appears to be present in very low quantities (< 10 infectious particles [IP]/ml) in plasma, serum, saliva (< 1 IP/ml), tears, urine, and genital secretions [38, [40] [41] [42] 47] . Infectious HIV has been cultured from cell-free seminal fluid at frequencies ranging from 11% [64] to 30% [46, 65] of specimens from seropositive persons.
Three reports have documented isolation of HIV from semen by co-cultivation techniques with mononuclear cells present in the ejaculate [36, 37, 39] . Three other reports have shown that HIV can readily be found in semen and vaginal secretions associated with viable, infected cells, often in great quantity, by co-cultivation with seminal mononuclear cells [38, 40, 42] ; and in situ hybridization has shown that the number of infected cells in semen from various individuals can range from 0.01% to 5% [46] . Given that normal seminal fluid contains, on average, 3 x 106 mononuclear cells/ ml [66] , and that the number could markedly increase during inflammation, infected white blood cells in semen could be a major source for transference of HIV.
The evidence implicating HIV transmission by infected cells is not surprising when one considers how other closely [28, 67] , and visna in sheep is passed almost exclusively by infected macrophages [29, 30] . We have also shown, in vitro, that HTLV-I is transmitted to epithelia by a lymphocyte-mediated mechanism [48] .
Time-lapse films of the association between HIV-infected lymphocytes and epithelia revealed cell-cell adhesion to be a dynamic process. Lymphocytic cells typically adhere to a particular epithelial cell for a few minutes and then move to another region of the cell or to a neighboring cell. When sites of associating HIV-infected lymphocytes and epithelial cells are viewed in the electron microscope, numerous virions are seen between the associated cells such that lymphocytes may be constantly shedding virions as they move about on the epithelial surface. This suggests that a single HIV-infected lymphocyte could serve as a vector to infect several epithelial cells.
The phenomena of movement on an epithelial surface and directional secretion are not surprising when one considers normal lymphocyte behavior. Lymphocyte function requires adherence and interaction with several other cell types. These interactions are typically transient and directional, for example, in CTL-mediated killing of target cells [68] or the secretion of soluble factors by CD4+ T lymphocytes in response to antigen-presenting cells [69] . Although interactions of cells of the immune system involve specific cell adhesion molecules, they are typically shortterm interactions: after two cells interact they dissociate and go on to other activities. It appears, from our studies, that HIV has evolved a mechanism to infect epithelia that utilizes natural properties of cells of the immune system.
Model systems that employ transformed cell lines are attractive because the cells can be easily obtained and cultured for long periods of time, and also because variations in the properties of cells from one experiment to another are minimal. However, because culture systems may differ from conditions in the body, it is important to establish the relevance of the in vitro system to the situation in nature. For instance, during sexual transmission of HIV, lymphocytes must contact seminal fluid, which is known to be immunosuppressive [70] [71] [72] . One possible mechanism for immunosuppression is inhibition of cell-cell interactions [73] . Therefore, it was important to determine whether seminal fluid might inhibit adhesion of lymphocytes to epithelia. Surprisingly, the contrary proved true; seminal fluid consistently enhanced attachment of both uninfected and HIVinfected lymphocytes. If the factor(s) in semen that enhance attachment can be characterized, it may be possible to develop ways to inhibit adherence.
Most of the work reported here was carried out with uninfected established cell lines: established cell lines are easier to work with than primary cell lines, and uninfected cells can be more safely screened than HIV-infected cells for anti-cell adhesion compounds. However, cell adhesion properties may differ between circulating HIV-infected lymphocytes and uninfected established lymphocytic cell lines. We have conducted limited experiments with HIV-infected lymphocytic cells or circulating lymphocytes from normal individuals. Results for HIV-infected cells are presented in Figures 13 and 15 . Chronically HIV-infected cells are more adhesive than uninfected cells, although adhesion is enhanced by semen just as much as in uninfected cells. Our observations on limited experiments with peripheral blood lymphocytes show that these adhere to ME-180 epithelial cells in a dose-dependent manner. It would be difficult to conduct experiments with HIV-infected peripheral blood lymphocytes since an infected culture of primary lymphocytes is a mixture of live uninfected and infected cells, syncytial cells, and dead or dying cells. However, our results with HIV-infected established cells and uninfected primaries suggest that uninfected established cell lines accurately mimic the situation that occurs during adherence of HIVinfected lymphocytes to epithelia in the human body.
A vaginal formulation containing an agent that could inhibit adherence of lymphocytes to epithelia might be effective in reducing the chances of HIV infection through sexual contact. For this reason, using a fluorescence-based cell-cell adhesion assay, we tested some compounds for their ability to inhibit adhesion. This assay was considerably quicker and more sensitive than the biotinylation method [61] ; it has the added advantage of labeling the cell cytoplasm rather than the cell membrane, an important consideration in a cell-cell adhesion assay.
Although many compounds are reported to have spermicidal activity, only surfactants are approved in the USA. N-9 is the surfactant in almost all commercial products. Although N-9 kills HIV [74] [75] [76] [77] [78] , there has been considerable concern that N-9 and other detergents may enhance the spread of HIV infection by causing micro-ulcerations of the epithelial lining of the genital tract [77, 79] . This could increase the susceptibility of a man or woman to viral infection, particularly if the individual subsequently has sexual intercourse without using a spermicide. Some of the evidence suggesting that spermicides may cause minor ulcerations to the reproductive epithelium comes from vaginal irritability studies in animals [80] [81] [82] . In addition, a considerable number of tolerability studies in women and men have concluded that the use of spermicides containing N-9 may cause genital discomfort during sexual activity [83, 84] . Thus, there is a need to develop a vaginal formulation that can simultaneously prevent conception and reduce the probability of HIV infection without causing micro-ulcerations of the genital epithelium. In our assay, N-9 had no effect on lymphocyte-to-epithelial cell adhesion below its cytotoxic concentration, suggesting that it does not have a specific effect on cell adhesion. Similarly, the detergent benzalkonium chloride, which is also used as a vaginal spermicide, did not affect cell adhesion at concentrations below cytotoxic levels. Compounds that have no effect in blocking adhesion below cytoxic levels may not be good candidates in a vaginal formulation to prevent cell-mediated HIV infection. These are only two of the many compounds that are reported to have spermicidal activity. In addition to compounds that did not inhibit adhesion and those that did so, there were compounds among those tested that enhanced adhesion. The most notable of these was proflavine.
We observed that the sulfated polysaccharide dextran sulfate significantly inhibited adhesion of uninfected lymphocytes at more than 100 times below its cytotoxic dose. Dextran sulfate also inhibited HIV-infected lymphocyte adhesion to epithelia. Comparing the effect of dextran sulfate between uninfected and HIV-infected lymphocytes, however, 12.5 mg/ml of dextran sulfate inhibited cell-cell adhesion by 88% in uninfected lymphocytes and by 34% in HIV-infected lymphocytes. Higher concentrations of dextran sulfate were undoubtedly more effective in blocking HIV-infected lymphocyte adhesion, e.g., 50 mg/ml blocked cell-cell adhesion 80%. It is clear that the ability of dextran sulfate to block cell-cell adhesion is dose-dependent; and not surprisingly, higher concentrations are required to block HIV-infected lymphocyte adhesion to epithelia, since HIVinfected lymphocytes are inherently more adherent than uninfected lymphocytes.
The first observations that sulfated polysaccharides could inhibit virus infection in vitro were carried out twenty-eight years ago with the herpes virus [85] . Although there has been little interest in these compounds for treatment of viral diseases, in the past five years more than a dozen papers have reported that dextran sulfate and other sulfated polysaccharides inhibit HIV infection of lymphocytes between 100 and 1000 times below cytotoxic levels [e.g., [54] [55] [56] 86] . The main interest in this class of compounds is for treatment of HIV-infected individuals, and Phase I clinical testing has already been initiated [87] . The in vitro evidence indicates that sulfated polysaccharides act by coating virions [88] and cells [89, 90] , and there is some evidence that they may also inhibit reverse transcriptase [91, 92] . The observations presented here suggest that these compounds coat cells since they prevent cell-cell adhesion. Dextran sulfate has other properties that make it an attractive candidate for a vaginal anti-HIV formulation. It is inexpensive, water-soluble, and poorly absorbed [93, 94] ; and it has been used systemically for treatment of other indications for twentyfive years [95] . In addition to dextran sulfate, glutathione also inhibited cell-cell adhesion; however, higher concentrations of both compounds were required to inhibit adhesion to epithelia of H1V-infected lymphocytes compared to uninfected lymphocytes. As is the case with sulfated polysaccharides such as heparin and chondroitin sulfate, glutathione is present in large amounts throughout the body and thus is virtually nontoxic.
There is a pressing need for a vaginal formulation that will prevent HIV transmission. The need arises not only because of the problems of the cytotoxicity of surfactants, which can result in micro-ulcerations of the genital tract, but also because individuals who wish to conceive may not accept a spermicide. We suggest that sulfated polysaccharides are very promising as active ingredients for a nontoxic vaginal formulation that will protect women and men from sexual transmission of HIV.
